The risk of greater COVID-19 severity and death is higher in people with BMI>30 according to a study published in the European Journal of Endocrinology. The study findings showed that BMI>30 was associated with a significantly higher risk of respiratory failure, admission to intensive care and death in COVID-19 patients, regardless of age, gender and other associated diseases.
A new Northwestern Medicine remote weight-loss programme, called Opt-IN, provides maximum weight loss for the lowest cost and with much less hassle than the gold-standard National Diabetes Prevention Program (DPP), according to the outcomes from a clinical trial. The DPP is claimed to be the most successful behavioural non-drug treatment currently available. Outcomes from the Opt-IN programme show that participants in a clinical trial lose 11 to 13lbs, which is equivalent to the DPP's success rate.
Users of public insurance are paying more for bariatric surgery compared to private insurance patients, according to researchers the University of Georgia.
Prior bariatric surgery (prior-BS) in type 2 diabetes mellitus (T2DM) patients undergoing noncardiac surgery is associated with a lower risk of major adverse cardiovascular and cerebrovascular events (MACCEs), according to researchers from The First Affiliated Hospital, Sun Yat-Sen University, South China University of Technology, Guangzhou and the Second Military Medical University, Shanghai, China.
IFSO Endoscopy Committee has published a Position Statement on the best practise of bariatric endoscopy in response to the CVOID-19 pandemic. The statement offers guidance on navigating bariatric endoscopic procedures in patients with obesity during the COVID-19 pandemic, in the hope of mitigating the risk of SARS-CoV-2 transmission to vulnerable patients and healthcare workers. The statement acknowledges that the recommendations may evolve as the pandemic progresses.